Srini Akkaraju

Srini is a senior advisor to Sofinnova Ventures. Previously, he was a general partner of Sofinnova Ventures, managing director of New Leaf Venture Partners, and cofounder and managing director at Panorama Capital, a private equity firm founded by the former venture capital investment team of J.P. Morgan Partners. Srini previously was a partner with J.P. Morgan Partners and worked in business and corporate development at Genentech. Srini serves on the boards of Seattle Genetics, Varsartis, Intercept Pharmaceuticals and aTyr Pharma. He previously served on the boards of Barrier Therapeutics, Eyetech Pharmaceuticals, Synageva Biopharma Corp. and ZS Pharma, all publicly traded biotechnology companies, and Amarin Corporation plc, a foreign publicly traded biotechnology company.